United States News All stories

Douglas Dynamics (NYSE:PLOW) announced that its Board of Directors declared a third-quarter 2026 cash dividend of $0.295 per share.

Hurco (NASDAQ:HURC) reported third-quarter 2026 net income of $2.3 million, or $0.35 per diluted share, compared with a net loss of $3.7 million, or $(0.58) per share, in the prior-year period.

Dine Brands Global (NYSE:DIN) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share of common stock.

Sabine Royalty Trust (NYSE:SBR) declared a monthly cash distribution of $0.331680 per unit, payable on September 29, 2026, to holders of record as of September 15, 2026.

Azenta (NASDAQ:AZTA) received full early repayment of a $35 million secured vendor loan related to the sale of B Medical Systems to Thelema S.à r.l.

Clearmind Medicine (NASDAQ:CMND) signed a definitive agreement to acquire a 51% stake in EV wireless charging company Charging Robotics for an aggregate purchase price of $2.5 million.

Tradeweb Markets (NASDAQ:TW) reported August 2026 total trading volume of $61.2 trillion, with average daily volume increasing 13.7% year over year to $2.8 trillion.

BioStem Technologies (NASDAQ:BSEM) announced that its VENDAJE® and VENDAJE AC® placental-derived wound care allografts have been added to existing contracts with Vizient and Premier, allowing hospitals to order the products immediately.

Baker Hughes (NASDAQ:BKR) received a contract from BP for offshore stimulation services supporting new well development and enhanced recovery activities in the UK North Sea.

USA Rare Earth (NASDAQ:USAR) completed its combination with Serra Verde Group on September 3, 2026, creating an integrated rare earth and permanent magnet platform spanning Brazil, the United States, the United Kingdom, and France.

Miami International Holdings (NYSE:MIAX) reported August 2026 trading metrics showing record year-to-date U.S. multi-list options activity, with average daily volume reaching 11 million contracts through August.

The Trade Desk (NASDAQ:TTD) announced an organizational realignment plan that will reduce its total workforce by approximately 15% as part of efforts to adjust resources and improve operational effectiveness.

RTX (NYSE:RTX) announced that its Pratt & Whitney business will invest $25 million to expand its engine parts manufacturing facility in Niepołomice, Poland.

Dorian LPG (NYSE:LPG) entered an agreement with Hanwha Ocean to build three 90,000 cubic meter dual-fuel Panamax very large gas carriers (VLGCs) for approximately $345 million.

Immuron (NASDAQ:IMRN) announced an exclusive U.S. distribution agreement with Calmino group AB for PROIBS®, a digestive health product designed to support abdominal comfort and intestinal health.

Douglas Emmett (NYSE:DEI) announced that its Board of Directors declared a quarterly cash dividend of $0.19 per share of common stock, representing an annualized dividend of $0.76 per share.

Stoke Therapeutics (NASDAQ:STOK) and Biogen (NASDAQ:BIIB) reported long-term clinical data for investigational Dravet syndrome treatment zorevunersen from Phase 1/2a and open-label extension studies.

Ionis Pharmaceuticals (NASDAQ:IONS) announced that the U.S. Food and Drug Administration approved ZANVASTRO (zilganersen) for pediatric and adult patients with Alexander disease, making it the first disease-modifying treatment approved for the condition.

United Microelectronics Corporation (NYSE:UMC) reported unaudited August 2026 net sales of NT$25.04 billion, increasing 30.71% year over year from NT$19.16 billion in August 2025.

Oil prices were little changed on Friday but remained on track for their strongest weekly increase since mid-July as rising tensions between the United States and Iran increased concerns about Middle East supply risks.

Zscaler (NASDAQ:ZS) reported fourth quarter fiscal 2026 results with revenue increasing 25% year over year to $898.2 million and annual recurring revenue reaching $3.771 billion.

DocuSign (NASDAQ:DOCU) reported second quarter fiscal 2027 revenue of $875.7 million for the period ended July 31, 2026, up 9% year over year, while increasing adoption of its Intelligent Agreement Management platform.

Milestone Pharmaceuticals (NASDAQ:MIST) received regulatory approval from China's National Medical Products Administration for its etripamil nasal spray, triggering a $2 million milestone payment.

Pharvaris (NASDAQ:PHVS) presented translational, nonclinical, and clinical data on its oral bradykinin B2 receptor antagonist deucrictibant at the Bradykinin Symposium 2026 in Berlin.